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ON A NONLINEAR MODEL FOR TUMOR GROWTH
WITH DRUG APPLICATION
DONATELLA DONATELLI AND KONSTANTINA TRIVISA
Abstract. We investigate the dynamics of a nonlinear system mod-
eling tumor growth with drug application. The tumor is viewed as a
mixture consisting of proliferating, quiescent and dead cells as well as a
nutrient in the presence of a drug. The system is given by a multi-phase
flow model: the densities of the different cells are governed by a set of
transport equations, the density of the nutrient and the density of the
drug are governed by rather general diffusion equations, while the veloc-
ity of the tumor is given by Brinkman’s equation. The domain occupied
by the tumor in this setting is a growing continuum Ω with boundary ∂Ω
both of which evolve in time. Global-in-time weak solutions are obtained
using an approach based on penalization of the boundary behavior, dif-
fusion and viscosity in the weak formulation. Both the solutions and
the domain are rather general, no symmetry assumption is required and
the result holds for large initial data. This article is part of a research
program whose aim is the investigation of the effect of drug application
in tumor growth.
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2 DONATELLI AND TRIVISA
1. Introduction
1.1. Motivation. The investigation of the effect of drug application in the
treatment of cancer is the subject of intense scientific effort. A major cause
of the failure of chemotherapeutic treatments for cancer is the development
of resistance to drugs. This article is part of a research program whose aim
is the investigation of the effect of drug application on tumor growth. We
investigate the dynamics of a nonlinear system describing the evolution of
cancerous cells. In this setting, the tumor is viewed as a mixture consisting of
proliferating, quiescent and dead cells in the presence of a nutrient (oxygen)
and drug. The mathematical model presented here is governed by
• a system of transport equations, which describe the evolution of the
densities of the cells that are present in the tumor: proliferating cells
with density P , quiescent cells with density Q and dead cells with
density D (this part of the tumor includes what is known also as
waste or extra-cellular medium),
• two rather general diffusion equations which are used to describe
the diffusion of the nutrient (oxygen) within the tumor region and
the evolution of the drug within the same regime. In general, these
equations obey Fick’s law: the nutrient is consumed at a rate pro-
portional to the rate of cell mitosis, whereas the drug is consumed
at a rate which is determined by the drug effectiveness,
• an extension of the Darcy law, known as Brinkman’s equation, which
determines the velocity field. The continuous movement within the
tumor region is due to proliferation, mitosis, apoptosis or removal of
cells. Note, the tumor in the present context is viewed as a fluid-like
porous medium.
Motivated by the experiment of Roda et al. (2011, 2012) and the mathe-
matical analysis in Friedman et al. [12], [13], and Zhao in [25] our model is
based on the following biological principles:
[P1] Living cells are either in a proliferating phase or in a quiescent phase.
[P2] Proliferating cells die as a result of apoptosis, which is a cell-loss
mechanism. Quiescent cells die in part due to apoptosis and more
often due to starvation. In fact the proliferation and the necrotic
death rates of tumor cells depend on the oxygen level.
[P3] The dead tumor cells are obtained from necrosis and apoptosis of
live tumor cells, and they are cleared by macrophages.
[P4] Living cells undergo mitosis, a process that takes place in the nucleus
of a dividing cell.
[P5] Cells change from quiescent phase into proliferating phase at a rate
which increases with the nutrient level, and they die at a rate which
increases as the level of nutrient (oxygen) decreases.
[P6] Proliferating cells become quiescent and die at a rate which increases
as the nutrient concentration decreases. The proliferation rate in-
creases with the nutrient concentration.
[P7] Proliferating cells and quiescent cells become dead cells at a rate
which depends on the drug concentration.
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The tumor region Ωt := Ω(t) is contained in a fixed domain B and the
region B \Ωt represents the healthy tissue (see Figure 1). The tumor region
Ωt and its boundary ∂Ωt evolve with respect to time. Both live and dead
tumor cells are assumed to be in the tumor region Ωt; oxygen molecules can
diffuse throughout the whole domain B. Abnormal proliferation of tumor
cells generates internal pressure in Ω(t), resulting to a velocity field v 6= 0
(while v = 0 in B \ Ωt). 
Tumor 
! 
"(t)
 B 
Healthy Region 
Figure 1. Healthy tissue - Tumor regime.
1.2. Governing equations of cells, oxygen and drug.
1.2.1. Transport equations for the evolution of the cell densities. All the cells
are assumed to follow the general continuity equation:
∂%
∂t
+∇ · (%v) = G,
where % may represent densities of proliferating/quiescent and dead cells.
The function G includes in general proliferation, apoptosis or clearance of
cells, and chemotaxis terms as appropriate.
Due to proliferation and removal of cells, there is a continuous motion
within the tumor represented by a velocity field v. We assume that there
are three types of cells: proliferative cells with density P, quiescent cells
with density Q and dead cells with density D in the presence of a nutrient
(oxygen) with density C and a drug with density W. The rates of change
from one phase to another are functions of the nutrient concentration C:
P → Q at rate KQ(C),
Q→ P at rate KP (C),
P → D at rate KA(C),
Q→ D at rate KD(C),
where KA stands for apoptosis. Finally, dead cells are removed at rate KR
(independent of C), and the rate of cell proliferation (new births) is KB.
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1.2.2. The tumor tissue as a porous medium. Due to proliferation and re-
moval of cells there is continuous motion of cells within the tumor; this
movement is represented by the velocity field v given by an alternative to
Darcy’s equation known as Brinkman’s equation
∇σ = − µ
K
v + µ∆v. (1.1)
where σ denotes the pressure, µ is a positive constant describing the viscous
like properties of tumor cells, whereas K denotes the permeability.
Relation (1.1) includes two viscous terms. The first term is the usual
Darcy law and the second is analogous to the Laplacian term that appears
in the Navier-Stokes equation. At a first look, (1.1) appears as an over
damped force balance. A second interpretation of this relation states that
the tumor tissue is “fluid like” and that the tumor cells flow through the
fixed extracellular matrix like a flow through a porous medium, obeying
Brinkman’s law.
The mass conservation laws for the densities of the proliferative cells P,
quiescent cells Q and dead cells D in Ω(t) take the following form:
∂P
∂t
+ div(Pv) = GP , (1.2)
∂Q
∂t
+ div(Qv) = GQ, (1.3)
∂D
∂t
+ div(Dv) = GD. (1.4)
Following Friedman [12], the source terms {GP,GQ,GD} are of the follow-
ing form:
GP =
(
KBC −KQ(C¯ − C)−KA(C¯ − C)
)
P +KPCQ− i1G1(W )P, (1.5)
where G1(·) a smooth function and KB, KQ, KA are positive constants.
The first term in this equation accounts for the increase of the number of
cells due to new births, loss due to change of phase from proliferating to
quiescent and loss due to apoptosis. The second term reflects the increase
of the number of proliferating cells generated from quiescent cells, whereas
the third term accounts for the decrease of the number of cells due to death
resulting from the effect of drug. In an analogous fashion
GQ = KQ(C¯ − C)P −
(
KPC +KD(C¯ − C)
)
Q− i2G2(W )Q, (1.6)
with G2(·) a smooth function and KP , KQ, KD positive constants. In the
above relations (1.5)-(1.6) i1G1(W ) and i2G2(W ) denote the rates by which
the proliferating cells and the quiescent cells become dead cells due to the
drug. Finally,
GD = KA(C¯−C)P+KD(C¯−C)Q−KRD+i1G1(W )P+i2G2(W )Q. (1.7)
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1.2.3. A linear diffusion equation for the evolution of nutrient. Tumor cells
consume nutrients (oxygen). In contrast to the equations of cell densities,
the equations of the oxygen molecules in the tumor include diffusion terms
in the following form:
∂C
∂t
= ∇ · (ν1∇C)−
(
K1KPCP +K2KQ(C¯ − C)Q
)
C.
Assuming that ν1 is constant this equation (cf. Friedman [12]) becomes
∂C
∂t
= ν1∆C −
(
K1KPCP +K2KQ(C¯ − C)Q
)
C. (1.8)
This equation describes the diffusion of the oxygen in the tumor region.
According to (cf. Ward and King [22], [23]) the nutrient is consumed at a
rate proportional to the rate of cell mitosis, namely the second term on the
right-hand side of the first equation in (1.8). We also refer the reader to
Friedman [12] where a class of relevant tumor growth models are presented
and the evolution of the nutrient is given by a related equation.
1.2.4. A linear diffusion equation for the evolution of drug. The evolution
of the drug concentration in the tumor is given by a diffusion equation of
the form
∂W
∂t
= ∇ · (ν2∇W )− (µ1G1(W )P + µ2G2(W )Q)W,
with G1(·), G2(·) smooth functions.
Assuming that ν2 is constant this equation (cf. Zhao [25]) becomes
∂W
∂t
= ν2∆W − (µ1G1(W )P + µ2G2(W )Q)W. (1.9)
This equation describes the diffusion of the drug within the tumor region.
The second term of the right-hand side of (1.9) represents the drug consump-
tion, the constants µ1, µ2 are two positive constants which can be viewed as
a measure of the drug effectiveness. We refer the reader to Ward and King
[22, 24] and Zhao [25] for further comments.
The total density of the mixture is denoted by %f and is given by
%f = P +Q+D = Constant. (1.10)
Adding (1.2)-(1.4) and taking into consideration (1.10) we arrive at the
following relation, which represents an additional constraint
ρf div v = GP +GQ +GD = KBCP −KRD. (1.11)
Our aim is to study the system (1.1)-(1.11) in a spatial domain Ωt, with
a boundary Γ = ∂Ωt varying in time.
1.3. Boundary behavior. The boundary of the domain Ωt occupied by
the tumor is described by means of a given velocity V (t,x), where t ≥ 0
and x ∈ R3. More precisely, assuming V is regular, we solve the associated
system of differential equations
d
dt
X(t,x) = V (t,X), t > 0, X(0,x) = x,
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and set {
Ωτ = X(τ,Ω0), where Ω0 ⊂ R3 is a given domain,
Γτ = ∂Ωτ , and Qτ = {(t, x)|t ∈ (0, τ), x ∈ Ωτ} .
The model is closed by giving boundary conditions on the (moving) tumor
boundary Γτ . More precisely, we assume that the boundary Γτ is imperme-
able, meaning
(v − V ) · n|Γτ = 0, for any τ ≥ 0. (1.12)
In addition, for viscous fluids, Navier proposed the boundary condition of
the form
[Sn]tan|Γτ = 0, (1.13)
with S denoting the viscous stress tensor which in this context is assumed
to be determined through Newton’s rheological law
S = µ
(
∇v +∇⊥v − 2
3
div vI
)
+ ξ div vI,
where µ > 0, ξ ≥ 0 are respectively the shear and bulk viscosity coefficients.
Condition (1.13) namely says that the tangential component of the normal
viscous stress vanishes on Γτ .
The concentrations of the nutrient and the drug on the boundary satisfy
the conditions:
C(x, t)|Γt = 0, W (x, t)|Γt = 0. (1.14)
Finally, the problem (1.2)-(1.14) is supplemented by the initial conditions{
P (0, ·) = P0, Q(0, ·) = Q0, D(0, ·) = D0,
C(0, ·) = C0 ≤ C¯, W (0, ·) = W0 in Ω0.
(1.15)
Our main goal is to show the existence of global in time weak solutions to
(1.1)-(1.15) for any finite energy initial data. Related works on the math-
ematical analysis of cancer models have been presented by Zhao [25] based
on the farmework introduced by Friedman et al. [12], [13]. The analysis in
[12], [13] yields existence and uniqueness of solution to a related model in
the radial symmetric case for a small time interval [0, T ]. The analysis in [25]
treats a parabolic-hyperbolic free boundary problem and provides a unique
global solution in the radially symmetric case. In the forth mentioned ar-
ticles the tumor tissue is assumed to be a porous medium and the velocity
field is determined by Darcy’s Law
v = −∇xσ in Ω(t).
In [9], Donatelli and Trivisa establish the global existence of weak so-
lutions to a nonlinear system modeling tumor growth in a general moving
domain Ωt ⊂ R3 without any symmetry assumption and for finite large
initial data. The article [9] is according to our knowledge the first article
treating the problem in a general setting. In [?] the same authors estab-
lish the global existence of weak solutions to a nonlinear system for tumor
growth in the case of variable total density of cells within a cellular medium.
The present article extends earlier results in a variety of ways. First the
effect of drug application is being considered within a moving domain in
R3 without any symmetry considerations. Second, the transport equations
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are rather general capturing more effectively the biological setting. Our
framework relies on biologically grounded principles [P1]− [P7], which are
motivated by experiments performed by Roda et al. [18] [?], [19] and provide
a description of the dynamics of the population of cells within the tumor.
We establish the global existence of weak solutions to (1.1)-(1.15) on time
dependent domains, supplemented with slip boundary conditions. In the
center of our approach lie the so-called generalized penalty methods typically
suitable for treating partial slip, free surface, contact and related boundary
conditions in viscous flow analysis and simulations. As has been seen in
earlier works, (cf. Carey and Krishnan [2], [3],[4], Donatelli and Trivisa [9])
penalty methods provide an additional weakly enforce constraint in the prob-
lem. This form of boundary penalty approximation appeared by Courant in
[6], in the context of slip conditions for stationary incompressible fluids by
Stokes and Carrey in [21], and more recently in a series of articles (cf. [9],
[?], [10], [11]). The existence theory for the barotropic Navier-Stokes system
on fixed spatial domains in the framework of weak solutions was developed
in the seminal work of Lions [14].
1.4. Outline. The paper is organized as follows: Section 1 presents the
motivation, modeling and introduces the necessary preliminary material.
Section 2 provides a weak formulation of the problem and states the main
result. Section 3 is devoted to the penalization problem and to the con-
struction of a suitable approximate scheme. The central component of the
approximating procedure is the addition of a singular forcing term
1
ε
∫
Γt
(v − V ) · nϕ · ndSx, ε > 0 small,
penalizing the normal component of the velocity on the boundary of the
tumor domain in the variational formulation of Brinkman’s equation. We
remark that applying a penalization method to the slip boundary conditions
is extremely delicate. Unlike for no-slip boundary condition, where the fluid
velocity coincides with the field V outside Ωτ , it is only its normal component
v · n that can be controlled in the case of slip. In order to treat the moving
boundary, additional penalizations on the viscosity and diffusion parameters
are required. In Section 4 we give a sketch on the existence of solutions of
the penalization scheme in the healthy tissue. In Section 5 we collect all
the uniform bounds satisfied by the solution of the penalization scheme. In
Section 6, the singular limits for ε → 0, ω → 0 are performed successively.
A key part in the penalization limit is to get rid of the terms supported in
the healthy tissue part ((0, T ) × B)\QT . The main issue is to describe the
evolution of the interface Γτ . To that effect we employ elements from the
so-called level set method (cf. Osher and Fedwik [17]).
2. Weak formulation and main results
2.1. Weak solutions.
Definition 2.1. We say that (P,Q,D,v, C,W ) is a weak solution of prob-
lem (1.1)- (1.7), (1.8), (1.9), (1.10) supplemented with boundary data sat-
isfying (1.12)-(1.14) and initial data (P0, Q0, D0, C0,W0) satisfying (1.15)
provided that the following hold:
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• (P,Q,D) ≥ 0 represents a weak solution of (1.2)-(1.3)-(1.4) on (0,∞)×
Ωτ , i.e., for any test function ϕ ∈ C∞c (([0, T ) × R3), T > 0 the following
integral relations hold∫
Ωτ
Pϕ(τ, ·) dx−
∫
Ω0
P0ϕ(0, ·)dx =∫ τ
0
∫
Ωt
(P∂tϕ+ Pv · ∇xϕ+GPϕ(t, ·)) dxdt,
∫
Ωτ
Qϕ(τ, ·) dx−
∫
Ω0
Q0ϕ(0, ·)dx =∫ τ
0
∫
Ωt
(Q∂tϕ+ Pv · ∇xϕ+GQϕ(t, ·)) dxdt,
∫
Ωτ
Dϕ(τ, ·) dx−
∫
Ω0
D0ϕ(0, ·)dx =∫ τ
0
∫
Ωt
(D∂tϕ+Dv · ∇xϕ+GDϕ(t, ·)) dxdt.

(I)
In particular,
P ∈ Lp([0, T ]; Ωτ ), Q ∈ Lp([0, T ]; Ωτ ), D ∈ Lp([0, T ]; Ωτ ) for all p ≥ 1.
We remark that in the weak formulation, it is convenient that the equa-
tions (1.2)-(1.4) hold in the whole space R3 provided that the densities
(P,Q,D) are extended to be zero outside the tumor domain.
• Brinkman’s equation (1.1) holds in the sense of distributions, i.e., for
any test function ϕ ∈ C∞c (R3;R3) satisfying
ϕ · n|Γτ = 0 for any τ ∈ [0, T ],
the following integral relation holds∫
Ωτ
σ divϕ dx−
∫
Ωτ
(
µ∇xv : ∇xϕ+ µ
K
vϕ
)
dx = 0. (2.1)
All quantities in (2.1) are required to be integrable, so in particular,
v ∈W 1,2(R3;R3),
and
(v− V ) · n(τ, ·)|Γτ = 0 for a.a. τ ∈ [0, T ].
• C ≥ 0 is a weak solution of (1.8), i.e., for any test function ϕ ∈
C∞c ([0, T )× R3), T > 0 the following integral relations hold∫
Ωτ
Cϕ(τ, ·) dx−
∫
Ω0
C0ϕ(0, ·)dx =
∫ τ
0
∫
Ωt
C∂tϕdxdt−∫ τ
0
∫
Ωt
ν1∇xC · ∇xϕdxdt−
∫ τ
0
∫
Ωt
(
K1KPCP +K2KQ(C¯ − C)Q
)
Cϕdxdt.
• W ≥ 0 is a weak solution of (1.9), i.e., for any test function ϕ ∈
C∞c ([0, T )× R3), T > 0 the following integral relations hold
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∫
Ωτ
Wϕ(τ, ·) dx−
∫
Ω0
W0ϕ(0, ·)dx =
∫ τ
0
∫
Ωt
W∂tϕdxdt−∫ τ
0
∫
Ωt
ν2∇xW · ∇xϕdxdt−
∫ τ
0
∫
Ωt
(µ1G1(W )P + µ2G2(W )Q)Wdxdt.
The main result of the article now follows.
Theorem 2.2. Let Ω0 ⊂ R3 be a bounded domain of class C2+ν and let
V ∈ C1([0, T ];C3c (R3;R3))
be given. Let the initial data satisfy
P0 ∈ Lp(R3), Q0 ∈ Lp(R3), D0 ∈ Lp(R3), for all p ≥ 1
and
C0 ∈ L2(R3) ∩ L∞(R3), W0 ∈ L2(R3) ∩ L∞(R3),
with (P0, Q0, D0, C0,W0) ≥ 0, (P0, Q0, D0, C0,W0) 6≡ 0,
P0 +Q0 +D0 = %f , (P0, Q0, D0, C0,W0)|R3\Ω0 = 0.
Then the problem (1.1)-(1.7), (1.8), (1.9)-(1.11) with initial data (1.15)
and boundary data (1.12)-(1.14) admits a weak solution in the sense specified
in Definition 2.1.
3. Penalization
3.1. General strategy. The main ingredients of our strategy can be for-
mulated as follows:
• Our approach relies on penalization of the boundary behavior, diffu-
sion and viscosity in the weak formulation. A penalty approach to
slip conditions for stationary incompressible flow was proposed by
Stokes and Carey [21] In the present setting, the variational (weak)
formulation of the Brinkman equation is supplemented by a singular
forcing term
1
ε
∫
Γt
(v − V ) · nϕ · ndSx, ε > 0 small, (3.1)
penalizing the normal component of the velocity on the boundary of
the tumor domain.
• In addition to (3.1), we introduce a variable shear viscosity coefficient
µ = µω, as well as a variable diffusions νi = νiω, i = 1, 2 with µω, νiω
vanishing outside the tumor domain and remaining positive within
the tumor domain.
• In constructing the approximating problem we employ the variables
ε and ω. Keeping ε and ω fixed, we solve the modified problem in a
(bounded) reference domain B ⊂ R3 chosen in such way that
Ω¯τ ⊂ B for any τ ≥ 0.
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• We take the initial densities (P0, Q0, D0) vanishing outside Ω0, and
letting the penalization ε → 0 for fixed ω > 0 we obtain a “two-
phase” model consisting of the tumor region and the healthy tissue
separated by impermeable boundary. We show that the densities
vanish in part of the reference domain, specifically on ((0, T )×B) \
QT .
• We let first the penalization ε vanish and next we perform the limit
ω → 0.
3.2. Penalization scheme. As typical in time dependent regimes the pe-
nalization can be applied to the interior of a fixed reference domains. In
that way we obtain at the limit a two-phase model consisting of the tumor
region Ωτ and a healthy tissue B \ Ωτ separated by an impermeable inter-
face Γτ . As a result an extra stress is produced acting on the fluid by its
complementary part outside Ωτ .
We choose R > 0 such that
V |[0,T ]×{|x|>R} = 0, Ω¯0 ⊂ {|x| < R}
and we take as the reference fixed domain
B = {|x| < 2R}.
In order to eliminate this extra stresses we introduce a variable shear
viscosity coefficient µ = µω(t,x) where, µ = µω remains strictly positive in
QT but vanishes in Q
c
T as ω → 0, namely µω is taken such that
µω ∈ C∞c
(
[0, T ]× R3) , 0 < µ
ω
≤ µω(t,x) ≤ µ in [0, T ]×B,
µω =
{
µ = const > 0 in QT
µω → 0 a.e. in ((0, T )×B)\QT
and a variable diffusion coefficients of the nutrient and the drug νi = νiω(t,x),
where νi = νiω, i = 1, 2 remain strictly positive in QT but vanishes in Q
c
T
as ω → 0, namely νiω are taken such that
νiω ∈ C∞c
(
[0, T ]× R3) , 0 < νiω ≤ νiω(t,x) ≤ νi in [0, T ]×B,
νiω =
{
νi = const > 0 in QT
νiω → 0 a.e. in ((0, T )×B)\QT .
Finally we modify the initial data for P , Q, D, C and W so that the following
set of relations denoted by (IC-p) read
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
P0 = P0,ω,ε = P0,ω, P0,ω ≥ 0, P0,ω 6≡ 0, P0,ω|R3\Ω0 = 0,
∫
B
P p0,ωdx ≤ c,
Q0 = Q0,ω,ε = Q0,ω, Q0,ω ≥ 0, Q0,ω 6≡ 0, Q0,ω|R3\Ω0 = 0,
∫
B
Qp0,ωdx ≤ c,
D0 = P0,ω,ε = D0,ω, D0,ω ≥ 0, D0,ω 6≡ 0, D0,ω|R3\Ω0 = 0,
∫
B
Dp0,ωdx ≤ c,
C0 = C0,ω,ε = C0,ω, C0,ω ≥ 0, C0,ω 6≡ 0, C0,ω|R3\Ω0 = 0,
∫
B
Cp0,ωdx ≤ c,
W0 = W0,ω,ε = W0,ω, W0,ω ≥ 0, W0,ω 6≡ 0, W0,ω|R3\Ω0 = 0,
∫
B
W p0,ωdx ≤ c,
for all p ≥ 1.
The weak formulation of the penalized problem reads:
• The integral relations (I) in Definition (2.1) hold true for any τ ∈
[0, T ] and x ∈ B and any test function ϕ ∈ C∞c ([0, T ]×R3), and for
GPω,ε ,GQω,ε ,GDω,ε given in (1.5)-(1.7), namely∫
B
Pω,εϕ(τ, ·) dx−
∫
Ω0
P0ϕ(0, ·)dx =∫ τ
0
∫
B
(
Pω,ε∂tϕ+ Pω,εvω,ε · ∇xϕ+GPω,εϕ(t, ·)
)
dxdt,
∫
B
Qω,εϕ(τ, ·) dx−
∫
Ω0
Q0ϕ(0, ·)dx =∫ τ
0
∫
B
(
Qω,ε∂tϕ+ Pω,εvω,ε · ∇xϕ+GQω,εϕ(t, ·)
)
dxdt,
∫
B
Dω,εϕ(τ, ·) dx−
∫
Ω0
D0ϕ(0, ·)dx =∫ τ
0
∫
B
(
Dω,ε∂tϕ+Dω,εvω,ε · ∇xϕ+GDω,εϕ(t, ·)
)
dxdt.

(Ip)
• The weak formulation for the penalized Brinkman’s equation reads∫
B
σω,ε divϕdx−
∫
B
(
µω∇xvω,ε : ∇xϕ+ µω
K
vω,εϕ
)
dx
+
1
ε
∫
Γt
((V − vω,ε) · nϕ · n)dSx = 0
(3.2)
for any test function ϕ ∈ C∞c (B;R3), where vω,ε ∈W 1,20 (B;R3), and
vω,ε satisfies the no-slip boundary condition
vω,ε|∂B = 0 in the sense of traces. (3.3)
• The weak formulation for Cω,ε is as follows,∫
B
Cω,εϕ(τ, ·) dx−
∫
Ω0
C0ϕ(0, ·)dx =
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0
∫
B
Cω,ε∂tϕdxdt−
∫ τ
0
∫
B
ν1ω∇xCω,ε · ∇xϕdxdt (3.4)
−
∫ τ
0
∫
B
(
K1KPCω,εPω,ε +K2KQ(C¯ − Cω,ε)Q
)
Cω,εϕdxdt,
for any test function ϕ ∈ C∞c ([0, T ] × R3) and Cω,ε satisfies the
boundary conditions
Cω,ε|∂B = 0 in the sense of traces. (3.5)
• The weak formulation for Wω,ε is as follows,∫
B
Wω,εϕ(τ, ·) dx−
∫
Ω0
W0ϕ(0, ·)dx =∫ τ
0
∫
B
Wω,ε∂tϕdxdt−
∫ τ
0
∫
B
ν2ω∇xWω,ε · ∇xϕdxdt (3.6)
−
∫ τ
0
∫
B
(µ1G1(Wω,ε)Pω,ε + µ2G2(Wω,ε)Qω,ε)Wω,εϕdxdt,
for any test function ϕ ∈ C∞c ([0, T ] × R3) and Wω,ε satisfies the
boundary conditions
Wω,ε|∂B = 0 in the sense of traces. (3.7)
Here, ε and ω are positive parameters.
4. Existence of Approximate Solutions within B
The construction of the approximate solutions
(Pω,ε, Qω,ε, Dω,ε, vω,ε, Cω,ε,Wω,ε)
within the fixed reference domain B relies
– on the regularization of the three transport equations (1.2)-(1.4) with
the aid of an artificial viscosity parameter η transforming the three
transport (hyperbolic) equations into parabolic partial differential
equations, and
– on the use of the so-called Faedo Garlerkin approximations on Brink-
man’s equation which involves replacing (1.1) by an integral relation.
The approximation at this level involves a parameter n, denoting the
dimension of the basis used in this process.
Given the approximate velocity, and the nutrient and drug concentrations
one solves the three parabolic equations corresponding to (1.2)-(1.4) via a
fixed point argument. Next, one solves the diffusion equations obtaining the
nutrient and the drug concentrations.
The loop closes by performing a fixed point argument on the integral form
of Brinkman’s equation yielding the approximate velocity. The existence
of the approximate solutions {Pω,ε, Qω,ε, Dω,ε, vω,ε, Cω,ε, Dω,ε} within B is
established by letting n→∞ and η → 0 in the spirit of the analysis in [7].
We emphasize at this point that by adding the three parabolic equations
of the approximate cell densities corresponding to (1.2)-(1.4) one obtains a
parabolic equation for the sum of cell densities [P +Q+D]{ω,ε,η,n}. At this
point we omit the indices for simplicity in the presentation.
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We recall that in Ωτ , (1.10) holds, namely P + Q + D = %f . A simple
argument shows that this sum is constant within the fixed reference domain
B as well. At this level one can argue by contradiction, namely assume that
P +Q+D = R(t) 6= %f
and write the equation verified by R(t) which is the following linear parabolic
equation
∂tR(t) + v∇R(t) = η∆R(t) + 1
%f
[KBCP −KRD][%f −R(t)]. (4.1)
supplemented with the initial data
R(0) = %f . (4.2)
Applying Gronwall’s inequality now yields uniqueness of solutions for (4.1)-
(4.2). Observing now, that R(t) = %f is a solution of (4.1)-(4.2) leads to
contradiction.
5. Uniform bounds
In this section we collect all the uniform bounds satisfied by the solutions
of the penalization schemes defined in the Section 3. Let us mention that
we will denote by c a constant that depends on the initial data (1.15),
the boundary conditions (1.13)-(1.14), %f , ‖Cω,ε‖L∞t,x , ‖Wω,ε‖L∞t,x . From the
previous section we get that
0 ≤ Pω,ε, Qω,ε, Dω,ε ≤ %f in [0, T ]×B, (5.1)
this entails that for any p ≥ 1
Pω,ε, Qω,ε, Dω,ε are uniformly bounded in L
p([0, T ]×B). (5.2)
Since the nutrient Cω,ε and the drug concentration satisfy a parabolic equa-
tion, by a standard application of the maximum principle [1] we have that
almost everywhere in B × (0, T )
Cω,ε(x, t) ∈ L∞([0, T ]×B). (5.3)
Wω,ε(x, t) ∈ L∞([0, T ]×B). (5.4)
Now, by multiplying (1.8) by Cω,ε, by integrating by parts and by taking
into account (5.1), (5.2), (5.3) we get that Cω,ε satisfies the following energy
estimate,
∂
∂t
∫
B
1
2
C2ω,εdx+
∫
B
ν1ω|∇xCω,ε|2dx ≤ c
∫
B
C2ω,εdx, (5.5)
similarly, taking into account that G1 and G2 are smooth functions we have
also
∂
∂t
∫
B
1
2
W 2ω,εdx+
∫
B
ν2ω|∇xWω,ε|2dx ≤ c
∫
B
W 2ω,εdx. (5.6)
As a consequence of (5.3), (5.4), (5.5), (5.6) we get the following uniform
bounds with respect to ε, ω.
‖Cω,ε‖L2tL2x + ‖ν1ω∇Cω,ε‖L2tL2x ≤ c, (5.7)
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‖Wω,ε‖L2tL2x + ‖ν2ω∇Wω,ε‖L2tL2x ≤ c, (5.8)
where LqtL
p
x stands for Lq(0, T ;L2(B)). By combining (5.2), (5.3) with (1.11)
we have that
div vω,ε = G, with G ∈ L∞(0, T ;Lp(B)), p > 1. (5.9)
Next, by applying regularity theory concerning the divergence equation in
Sobolev spaces (see Lemma 2.1.1 (a) in [20] or Remark 3.19 in [15], for more
details see also [9]) we end up with
‖∇vω,ε‖Lpx ≤ c‖G‖Lpx p > 1. (5.10)
Since the vector field V vanishes on the boundary of the reference domain B
it may be used as a test function in the weak formulation of the Brinkman’s
equation for the penalized problem (3.2), namely
∫
B
σω,ε divV dx−
∫
B
(
µω∇xvω,ε : ∇xV + µω
K
vω,εV
)
dx
+
1
ε
∫
Γt
((V − vω,ε) · nV · n)dSx = 0.
(5.11)
By combining standard computations with (5.11), the velocity field vω,ε
satisfies the following estimate,∫
B
µω(|∇xvω,ε|2 + 1
K
|vω,ε|2)dx+ 1
ε
∫
Γt
|(vω,ε − V ) · n|2dS ≤∫
B
(µω∇xvω,ε : ∇xV + µωvω,εV ) dx+
∫
B
σω,ε (div vω,ε − divx V ) dx.
Since the vector field V is smooth by means of (5.9), (5.11) and by con-
sidering the weak formulation of Brinkmann’s equation for the penalized
problem (3.2) in B once more with a special test function (for example by
employing the multipliers technique of Lions [14] for the pressure) we get
the following uniform bounds with respect to ε, ω.
‖σω,ε‖Lβx ≤ c, 1 < β ≤ 2 (5.12)
‖µωvω,ε‖L2x + ‖µω∇vω,ε‖L2x ≤ c, (5.13)
∫
Γt
|(vω,ε − V ) · n|2dS ≤ cε. (5.14)
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6. Singular limits
In this section we perform the limits of our two level penalization approx-
imation. The first step is to keep ω fixed and let ε → 0. The main issue
of this step is to get rid of the quantities that are supported by the healthy
tissue B\Ωt. This will be done by means of the Lemma 6.2 that we will
prove in the section. The second and final step is the vanishing viscosity
limit ω → 0 that we perform in Section 6.2 and this completes the proof of
our main result Theorem 2.2.
6.1. Vanishing penalization ε → 0. As a consequence of the uniform
bound (5.2) and the equations (1.2), (1.3), (1.4) we get that the weak solu-
tions of our approximation system satisfy
Pω,ε → Pω
Qω,ε → Qω
Dω,ε → Dω
 in Cweak(0, T ;L
p(B)), p ≥ 1. (6.1)
From the bound (5.7), (5.8) and (5.13) we get
Cω,ε −→ Cω weakly in L2(0, T ;W 1,20 (B)), (6.2)
Wω,ε −→Wω weakly in L2(0, T ;W 1,20 (B)), (6.3)
vω,ε −→ vω weakly in W 1,20 (B), (6.4)
while from (5.14) we have that
(vω,ε − V ) · n(τ, ·)
∣∣
Γτ
= 0 for a.a τ ∈ [0, T ].
By combining together (5.2), (5.13) and the compact embedding of L2(B)
in W−1,2(B)we get
Pω,εvω,ε → Pωvω
Qω,εvω,ε → Qωvω
Dω,εvω,ε → Dωvω
 weakly-(∗) in L
∞(0, T ;L2q/q+2(B)), 2 ≤ q < 6. (6.5)
Finally from the equations (1.2)-(1.4) it follows that
Pω,εvω,ε → Pωvω
Qω,εvω,ε → Qωvω
Dω,εvω,ε → Dωvω
 in Cweak([T1, T2];L
2q/q+2(B)), 2 ≤ q < 6. (6.6)
Since the embedding of W 1,20 (B) in L
6(B) is compact we have that
vω,ε ⊗ vω,ε → vω ⊗ vω weakly in L6q/6+q(B) for any 2 ≤ q < 6.
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Taking into account (5.2), (5.7), (5.8) and, as before, the compact embedding
of L2(B) in W−1,2(B) we get
Pω,εCω,ε → PωCω
Qω,εCω,ε → QωCω
Dω,εCω,ε → DωCω
Pω,εWω,ε → PωWω
Qω,εWω,ε → QωWω

weakly-(∗) in L∞(0, T ;L2q/q+2(B)), 2 ≤ q < 6. (6.7)
By using (5.12) and (6.4) we into the limit in the weak formulation (3.2) of
the Brinkman’s equation we get∫
B
σω divϕdx−
∫
B
(
µω∇xvω : ∇xϕ+ µω
K
vωϕ
)
dx = 0, (6.8)
for any test function ϕ ∈ C∞c (B;R3), ϕ · n|B = 0.
By using (5.13), (6.1)-(6.7) we can pass to the limit in the weak formula-
tions (Ip), (3.4), (3.6) and we obtain∫
B
Pωϕ(τ, ·)dx−
∫
B
P0ϕ(0, ·)dx =∫ τ
0
∫
B
(Pω∂tϕ+ Pωv · ∇xϕ+GPωϕ) dxdt,∫
B
Qωϕ(τ, ·)dx−
∫
B
Q0ϕ(0, ·)dx =∫ τ
0
∫
B
(Qω∂tϕ+Qωv · ∇xϕ+GQωϕ) dxdt,∫
B
Dωϕ(τ, ·)dx−
∫
B
D0ϕ(0, ·)dx =∫ τ
0
∫
B
(Dω∂tϕ+Dωv · ∇xϕ+GDωϕ) dxdt.

(IIp)
∫
B
Cωϕ(τ, ·) dx−
∫
Ω0
C0ϕ(0, ·)dx =∫ τ
0
∫
B
Cω∂tϕdxdt−
∫ τ
0
∫
B
ν1ω∇xCω · ∇xϕdxdt
−
∫ τ
0
∫
B
(
K1KPCωPω +K2KQ(C¯ − Cω)Q
)
Cωϕdxdt.
(6.9)
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∫
B
Wωϕ(τ, ·) dx−
∫
Ω0
W0ϕ(0, ·)dx =∫ τ
0
∫
B
Wω∂tϕdxdt−
∫ τ
0
∫
B
ν1ω∇xWω · ∇xϕdxdt
−
∫ τ
0
∫
B
(
µ2G1(Wω)Pω + µ2G2(Wω,ε)Qω
)
Wωϕ dxdt.
(6.10)
6.1.1. Vanishing density terms in the “healthy tissue”. The next step in the
penalization limit is to get rid of the terms supported in the healthy tissue
part ((0, T ) × B)\QT . The main issue is to describe the evolution of the
interface Γτ . To that effect we employ elements from the so-called level set
method. The level set method is a numerical method for tracking interfaces
and shapes (cf. Osher and Fedwik [17]). It turns out that the interface Γτ
can be identified with a component of the set
{Φ(τ, ·) = 0},
while the set B \Ωτ correspond to {Φ(τ, ·) > 0}, with Φ = Φ(t, x) denoting
the unique solution of the transport equation
∂tΦ +∇xΦ(t, x) · V = 0, (6.11)
with initial data
Φ0(x) =
{
> 0 for x ∈ B\Ω0,
< 0 for x ∈ Ω0 ∪ (R3\B),
∇xΦ0 6= 0 on Γ0.
Finally,
∇xΦ(τ, x) = λ(τ, x)n(x) for any x ∈ Γτ
λ(τ, x) ≥ 0 for τ ∈ [0, T ].
(6.12)
First we deal with the nutrient Cω and the drug concentration Wω. and
we prove that their are vanishing outside Ωτ .
Proposition 6.1. Assume that Cω, Wω satisfy (6.9) and (6.10), respectively
and that (IC-p) holds, then
Cω(τ, ·)|B\Ωτ = 0 Wω(τ, ·)|B\Ωτ = 0. (6.13)
Proof. In order to prove (6.13) it is enough to observe that Cδ,ω and Wδ,ω
are solutions in B\Ωτ of a parabolic equation with vanishing initial and
boundary data. 
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Now, thanks to the Proposition 6.1, the weak formulation (6.9) assumes
the following form∫
Ωτ
Cωϕ(τ, ·) dx−
∫
Ω0
C0ϕ(0, ·)dx =∫ τ
0
∫
Ωτ
Cω∂tϕdxdt−
∫ τ
0
∫
Ωτ
ν1ω∇xCω · ∇xϕdxdt
−
∫ τ
0
∫
Ωτ
(
K1KPCωPω +K2KQ(C¯ − Cω)Q
)
Cωϕ(τ, ·)dxdt.
(6.14)
while the drug concentration formulation (6.10) becomes∫
Ωτ
Wωϕ(τ, ·) dx−
∫
Ω0
W0ϕ(0, ·)dx =∫ τ
0
∫
Ωτ
Wω∂tϕdxdt−
∫ τ
0
∫
Ωτ
ν2ω∇xWω · ∇xϕdxdt
−
∫ τ
0
∫
Ωτ
(
µ1G1(Wω)Pω + µ2G2(Wω,ε)Qω
)
Wωϕ(τ, ·)dxdt.
(6.15)
In order to prove that the proliferating, quescient and dead cells are vanish-
ing in the healthy tissue we need to prove the following lemma.
Lemma 6.2. Let Z ∈ L∞(0, T ;L2(B)), Z ≥ 0, v ∈ W 1,20 (B) satisfying the
following equation∫
B
(
Zϕ(τ, ·)− Z0ϕ(0, ·)
)
dx
=
∫ τ
0
∫
B
(Z∂tϕ+ Zv · ∇xϕ+ (G+GZ)ϕ) dxdt,
(6.16)
for any τ ∈ [0, T ] and any test function ϕ ∈ C1c ([0, T ] × R3) and GZ a
linear function of Z, while G ∈ L∞([0, T ]×B), G(τ, ·)∣∣
B\Ωτ = 0. Moreover
assume that
(v − V )(τ, ·) · n∣∣
Γτ
= 0 a.e. τ ∈ (0, T ) (6.17)
and that
Z0 ∈ L2(R3), Z0 ≥ 0 Z0
∣∣
B\Ω0 = 0.
Then
Z(τ, ·)∣∣
B\Ωτ = 0 for any τ ∈ [0, T ]. (6.18)
Proof. In the proof it is crucial the construction of an appropriate test func-
tion to be used in the weak formulation of (6.16). For given η > 0 we
use
ϕ =
[
min
{
1
η
Φ; 1
}]+
(6.19)
and we obtain∫
B\Ωτ
Zϕdx =
1
η
∫ τ
0
∫
{0≤Φ(t,x)≤η}
(Z∂tΦ + Zv · ∇xΦ + (G+GZ)Φ) dxdt
+
∫ τ
0
∫
{Φ(t,x)>η}
GZdxdt.
(6.20)
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We have that
Z∂tΦ + Zv · ∇xΦ = Z(∂tΦ + v · ∇xΦ) = Z(v − V ) · ∇xΦ
where by (6.12) and (6.17) we get
(v − V ) · ∇xΦ ∈W 1,20 (B\Ωτ ) for a.e. t ∈ (0, τ). (6.21)
We introduce now the following distance function
δ(t, x) = distR3 [x, ∂(B\Ωτ )] for t ∈ [0, τ ], x ∈ B\Ωτ . (6.22)
From (6.21) and an application of Hardy’s inequality (see Theorem 21.5 in
[16]) it follows that
1
δ
(V − v) · ∇xΦ ∈ L2([0, τ ]×B\Ωτ ). (6.23)
On the other hand by taking into account that G is bounded and that GZ
is a linear function of Z and Z ∈ L∞(0, T ;L2(B)) and that (6.22) is defined
in R3 we have also
V +GZ√
δ
∈ L1([0, τ ]×B\Ωτ ). (6.24)
Since V is regular we have that
δ(t, x)
η
≤ c,
√
δ(t, x)
η
≤ c when 0 ≤ Φ(t, x) ≤ η. (6.25)
Going back to (6.20) we get∫
B\Ωτ
Zϕdx ≤ 1
η
∫ τ
0
∫
{0≤Φ(t,x)≤η}
δ
Z(v − V ) · ∇xΦ
δ
dxdt
+
1
η
∫ τ
0
∫
{0≤Φ(t,x)≤η}
√
δ
G+GZ√
δ
Φdxdt,+
∫ τ
0
∫
B\Ωt
GZdxdt
(6.26)
and letting η → 0 in (6.26) and by taking into account (6.19), (6.23), (6.24),
and that GZ is a linear function of Z and Z ∈ L∞(0, T ;L2(B)), by applying
Gronwall’s inequality we conclude with∫
B\Ωτ
Zdx = 0.
Therefore by using the fact that Z ≥ 0 and Z ∈ L∞(0, T ;L2(B)) we end up
with (6.18). 
By means of the previous lemma we are able to prove now that the pro-
liferating, quiescent, dead cells a are vanishing in the healthy tissue.
Proposition 6.3. Assume that Pω, Qω, Dω and Cω satisfy (IIp) and that
(IC-p) holds, then
Pω(τ, ·)|B\Ωτ = 0, Qω(τ, ·)|B\Ωτ = 0, Dω(τ, ·)|B\Ωτ = 0. (6.27)
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Proof. We start the proof with Pω. Byusing the Proposition 6.13 and the
uniform bounds of the Section 5 we see Pω verifies the hypotheses of the
Lemma 6.2 if we take
G = KpCωQω
and
Gz =
(
KBCω −KQ(C¯ − Cω)−KA(C¯ − Cω)
)
Pω − i1G1(Wω)Pω,
so we have that Pω(τ, ·)|B\Ωτ = 0. Having obtained the result for Pω, the
remaing part of the proof follows with the same type of arguments applied
to Qω and Dω. 
Now, taking into account the Proposition 6.3, Pω, Qω, Dω satisfy the
weak formulation (I) as ε→ 0.
6.2. Vanishing viscosity limit ω → 0. The last step in the proof is to
perform the limit ω → 0 in order to get rid of the last viscosity terms of
(6.8) in B\Ωt. By using (5.13) we have that∫
Ωt
µ
(|∇xvω|2 + |vω|2) dx ≤ c∫
B\Ωt
µω
(|∇xvω|2 + |vω|2) dx ≤ c, (6.28)
The estimates (6.28) with a standard computations yields that∫
B\Ωt
µω (∇xvω : ∇xϕ+ vω,εϕ) dx→ 0 as ω → 0. (6.29)
By combining (6.8) with (6.29) we get∫
B\Ωt
σω divϕdxdt = 0,
for any text function ϕ. Now in the same spirit of [8] we can let ω → 0
in the weak formulations (6.8), (6.14), (6.15) and we complete the proof of
Theorem 2.2.
7. Acknowlegments
The work of D.D. was supported by the Ministry of Education, Univer-
sity and Research (MIUR), Italy under the grant PRIN 2012- Project N.
2012L5WXHJ, Nonlinear Hyperbolic Partial Differential Equations, Disper-
sive and Transport Equations: theoretical and applicative aspects. K.T.
gratefully acknowledges the support in part by the National Science Foun-
dation under the grant DMS-1211519 and by the Simons Foundation under
the Simons Fellows in Mathematics Award 267399. Part of this research
was performed during the visit of K.T. at University of L’Aquila which was
supported under the grant PRIN 2012- Project N. 2012L5WXHJ, Nonlinear
Hyperbolic Partial Differential Equations, Dispersive and Transport Equa-
tions: theoretical and applicative aspects. This work was completed while
K.T. was resident at E´cole Normale Supe´rieure de Cachan as a Simons Fel-
low. K.T. is grateful to C. Bardos, L. Desvilettes and the CMLA Lab for
providing a very stimulating environment for scientific research and to C.
Villani and the Institute Henri Poincare´ for the hospitality.
ON A TUMOR GROWTH MODEL 21
References
[1] D. G. Aronson, and J. Serrin, Local behavior of solutions of quasilinear parabolic
equations, Arch. Rational Mech. Anal., 25, (1967), 81–122.
[2] G. Carey and R. Krishnan, Penalty approximation of Stokes flow, Parts I & II,
Comput. Methods Appl. Mech. Engrg. 35, (1982), 169-206.
[3] G. Carey and R. Krishnan, Penalty finite element method for the Navier-Stokes
equations, Parts I & II, Comput. Methods Appl. Mech. Engrg. 42, (1984) 183-224.
[4] G. Carey and R. Krishnan, Continuation techniques for a penalty approximation of
the Navier-Stokes equations, Comput. Methods Appl. Mech. Engrg. 48, (1985) 265-
282.
[5] D. Chen and A. Friedman, A two-phase free boundary problem with discontinuous
velocity: Applications to tumor model, J. Math. Anal. Appl. 399, (2013), 378-393.
[6] R. Courant, Calculus of Variation and Supplementary Notes and Exercises, New York
University, New York, NY, 1956.
[7] D. Donatelli, K. Trivisa, On the motion of a viscous compressible radiative-reacting
gas.Comm. in Math. Phys., 265, (2006), no. 2, 463-491.
[8] D. Donatelli, K. Trivisa, From the dynamics of gaseous stars to the incompressible
Euler equations. J. Differential Equations, 245, (2008) 1356-1385-606.
[9] D. Donatelli, K. Trivisa, On a nonlinear model for tumor growth: Global in time
weak solutions, J. Math. Fluid Mech., 16, (2014), 787–803.
[10] E. Feiresl, J. Neustupa, J. Stebel, Convergence of a Brinkman-type penalization for
compressible fluid flows. J. Differential Equations, 250, no.1, (2011) 596-606.
[11] E. Feireisl, O. Kreml, S. Necasova, J. Neustupa, J. Stebel, Weak solutions to the
barotropic Navier-Stokes system with slip boundary conditions in time dependent
domains, J. Differential Equations 254, (2013) 125-140.
[12] A. Friedman, A hierarchy of cancer models and their mathematical challenges, Dis-
crete and Continuous Dynamical Systems, 4, no. 1 (2004) 147-159.
[13] D. Chen and A. Friedman, A two-phase free boundary problem with discontinuous
velocity: Applications to tumor model, J. Math. Anal. Appl. 399 (2013) 378-393.
[14] P.-L. Lions, Mathematical topics in Fluid Dynamics, Vol. 2 Compressible models,
Oxford Science Publication, Oxford, 1998.
[15] A. Novotny, I. Straskraba, Introduction to the Mathematical Theory of Compressible
Flow, Oxford Science Publication, Oxford, 2004.
[16] B. Opic, A. Kufner, Hardy-type inequalities. Longman, Pitchman Research Notes in
Math. 219, Essex, 1990.
[17] S. Osher, R. Fedwik, Level Set Methods and Dynamic Implicit Surfaces, Appl. Math.
Sci., 153, Springer- Verlag, New York, 2003.
[18] J. M. Roda, L.A. Summer, R. Evans, G.S. Philips, C.B. Marsh and T.D. Eubank,
Hypoxia inducible factor-2 regulates GM-CSF-derived soluble vascular endothelial
growth factor receptor 1 production from macrophages and inhibits tumor growth
and angiogenesis. J. Immunol., 187, (2011), 1970–1976.
[19] J. Roda, Y. Wang, L. Sumner, G. Phillips, T. Eubank, and C. Marsh, Stabilization
of HIF-2 induces SVEGFR-1 production from Tumor-associated macrophages and
enhances the Anti-tumor effects of GM-CSF in murine melanoma model. J. Immunol.,
189, (2012), 3168–3177.
[20] H. Sohr, The Navier Stokes Equations, An Elementary Functional Analytical Ap-
proach, Birkha´user Verlag, Basel, 2001.
[21] Y. Stokes and G. Carey, On generalized penalty approaches for slip surface and related
boundary conditions in viscous flow simulation, Internat. J. Numer. Methods Heat
Fluid Flow, 21 (2011) 668-702.
[22] J.P. Ward and J.R. King, Mathematical modeling of avascular amour growth I, IMA
J. Math. Appl. Med. Biol. 14, no. 1 (1997), 39–69.
[23] J.P. Ward and J.R. King, Mathematical modeling of avascular amour growth II:
Modelling growth saturation, IMA J. Math. Appl. Med. Biol. 16, (1999), 171-211.
[24] J.P. Ward and J.R. King, Mathematical modeling of drug transport model in tumor
multicell spheroids, Math. Biosci., 181 (2003), 177-207.
22 DONATELLI AND TRIVISA
[25] J.-H. Zhao, A parabolic-hyperbolic free boundary problem modeling tumor growth
with drug application, Electronic Journal of Differential Equations, 2010, (2010)
1–18.
(Donatelli)
Departement of Engineering Computer Science and Mathematics, University
of L’Aquila, 67100 L’Aquila, Italy.
E-mail address: donatell@univaq.it
URL: univaq.it/~donatell
(Trivisa)
Department of Mathematics, University of Maryland, College Park, MD
20742-4015, USA.
E-mail address: trivisa@math.umd.edu
URL: math.umd.edu/~trivisa
